格爾軟件(603232.SH):擬以1000萬元對上海芯鈦進行增資
格隆匯7月9日丨格爾軟件(603232.SH)公佈,為加強公司車聯網安全行業佈局,推動公司自身穩定發展,發揮車聯網產業協同效應,公司與福沃德投資控股有限公司(“福沃德”)、嘉興創榮股權投資合夥企業(有限合夥)(“嘉興創榮”)、深圳市投控東海中小微創業投資企業(有限合夥)(“東海創投”)、上海火山石二期創業投資合夥企業(有限合夥)(“火山石二期”)擬對上海芯鈦進行增資。
公司擬以自有資金人民幣1000萬元對上海芯鈦進行增資,其中52.9097萬元計入上海芯鈦註冊資本,947.0903萬元計入上海芯鈦資本公積。本次增資完成後,公司持有上海芯鈦1.7391%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.